Archive for the ‘Cidara Therapeutics’ Category

Cidara Therapeutics

June 2nd, 2015 | Posted in 2015, Cidara Therapeutics

San Diego-based, Cidara Therapeutics (Nasdaq: CDTX) has received fast-track status for its leading proposed treatment for fungal infections, CD101 IV. This will give the drug priority review from the FDA.